{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:02:03Z","timestamp":1780822923318,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jad.2025.120437","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:47:10Z","timestamp":1760694430000},"page":"120437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?"],"prefix":"10.1016","volume":"394","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8111-6299","authenticated-orcid":false,"given":"Lauren N.","family":"Vale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4240-747X","authenticated-orcid":false,"given":"Maya","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-009X","authenticated-orcid":false,"given":"Leonardo","family":"F\u00e1varo-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-5628","authenticated-orcid":false,"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4236-7778","authenticated-orcid":false,"given":"Thomas D.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jad.2025.120437_bb0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapsychiatry.2023.4685","article-title":"Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial","volume":"81","author":"Aaronson","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.120437_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214503","article-title":"Validation of five facets mindfulness questionnaire\u2013short form, in Spanish, general health care services patients sample: prediction of depression through mindfulness scale","volume":"14","author":"Asensio-Mart\u00ednez","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jad.2025.120437_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1073191105283504","article-title":"Using self-report assessment methods to explore facets of mindfulness","volume":"13","author":"Baer","year":"2006","journal-title":"Assessment"},{"issue":"3","key":"10.1016\/j.jad.2025.120437_bb0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1073191107313003","article-title":"Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples","volume":"15","author":"Baer","year":"2008","journal-title":"Assessment"},{"issue":"1","key":"10.1016\/j.jad.2025.120437_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/psymed.2023.0036","article-title":"American psychiatrists\u2019 opinions about classic hallucinogens and their potential therapeutic applications: a 7-year follow-up survey","volume":"2","author":"Barnett","year":"2023","journal-title":"Psychedelic Med."},{"issue":"11","key":"10.1016\/j.jad.2025.120437_bb0030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2025.120437_bb0035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881116678781","article-title":"The challenging experience questionnaire: characterization of challenging experiences with psilocybin mushrooms","volume":"30","author":"Barrett","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120437_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neubiorev.2018.02.004","article-title":"Serotonergic psychedelics and personality: a systematic review of contemporary research","volume":"87","author":"Bouso","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.jad.2025.120437_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1037\/1040-3590.6.2.117","article-title":"Motivations for alcohol use among adolescents: development and validation of a four-factor model","volume":"6","author":"Cooper","year":"1994","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.jad.2025.120437_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/2470547020939564","article-title":"Psychedelic treatment for trauma-related psychological and cognitive impairment among US special operations forces veterans","volume":"4","author":"Davis","year":"2020","journal-title":"Chronic Stress"},{"key":"10.1016\/j.jad.2025.120437_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2022.876706","article-title":"Race, ethnic, and sex differences in prevalence of and trends in hallucinogen consumption among lifetime users in the United States between 2015 and 2019","volume":"2","author":"Davis","year":"2022","journal-title":"Front. Epidemiol."},{"key":"10.1016\/j.jad.2025.120437_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2019.1606472","article-title":"The past and future of psychedelic science: an introduction to this issue","volume":"51","author":"Doblin","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jad.2025.120437_bb0065","article-title":"Evaluating the risk of psilocybin for the treatment of bipolar depression: a review of the research literature and published case studies","volume":"6","author":"Gard","year":"2021","journal-title":"J. Affective Disord. Rep."},{"issue":"18","key":"10.1016\/j.jad.2025.120437_bb0070","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.120437_bb0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jad.2025.120437_bb0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0092-6566(03)00046-1","article-title":"A very brief measure of the Big-Five personality domains","volume":"37","author":"Gosling","year":"2003","journal-title":"J. Res. Pers."},{"key":"10.1016\/j.jad.2025.120437_bb0085","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: a prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.jad.2025.120437_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.addbeh.2011.11.025","article-title":"Validity of timeline follow-back for self-reported use of cannabis and other illicit substances\u2014systematic review and meta-analysis","volume":"37","author":"Hjorth\u00f8j","year":"2012","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2025.120437_bb0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2024.01.197","article-title":"Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom","volume":"351","author":"Honk","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120437_bb0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2307\/1385773","article-title":"Toward a theory of death transcendence","author":"Hood","year":"1983","journal-title":"J. Sci. Study Relig."},{"key":"10.1016\/j.jad.2025.120437_bb0105","article-title":"Psychedelics, mystical experience, and therapeutic efficacy: a systematic review","volume":"13","author":"Ko","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.120437_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2025.2461999","article-title":"Tripping into treatment: comparing initial and current motivations for psychedelic use","author":"Kruger","year":"2025","journal-title":"J. Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.jad.2025.120437_bb0115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-5906.2012.01685.x","article-title":"Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin","volume":"51","author":"MacLean","year":"2012","journal-title":"J. Sci. Study Relig."},{"issue":"3","key":"10.1016\/j.jad.2025.120437_bb0120","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1467-6494.2009.00559.x","article-title":"On the development of harmonious and obsessive passion: the role of autonomy support, activity specialization, and identification with the activity","volume":"77","author":"Mageau","year":"2009","journal-title":"J. Pers."},{"issue":"2","key":"10.1016\/j.jad.2025.120437_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14737175.2024.2445016","article-title":"Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective","volume":"25","author":"Marazziti","year":"2025","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.jad.2025.120437_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-53829-z","article-title":"Development and psychometric validation of a novel scale for measuring \u2018psychedelic preparedness\u2019","volume":"14","author":"McAlpine","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jad.2025.120437_bb0135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jad.2011.09.005","article-title":"Do patients with bipolar disorder drink alcohol for different reasons when depressed, manic or euthymic?","volume":"136","author":"Meyer","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120437_bb0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jad.2024.12.044","article-title":"Psychedelic use and bipolar disorder\u2013An investigation of recreational use and its impact on mental health","volume":"373","author":"Meyer","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2025.120437_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/02698811221131997","article-title":"Risks and benefits of psilocybin use in people with bipolar disorder: an international web-based survey on experiences of \u2018magic mushroom\u2019consumption","volume":"37","author":"Morton","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120437_bb0150","series-title":"The Measurement of Meaning","author":"Osgood","year":"1957"},{"issue":"1\u20133","key":"10.1016\/j.jad.2025.120437_bb0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jad.2007.08.020","article-title":"Accuracy of recall for mania symptoms using a three month timeline follow-back interview","volume":"107","author":"Simon","year":"2008","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.jad.2025.120437_bb0160","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120437_bb0165","series-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","first-page":"41","article-title":"Timeline follow-back: A technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"issue":"1","key":"10.1016\/j.jad.2025.120437_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1073191116638410","article-title":"Psychometric properties of a structured diagnostic interview for DSM-5 anxiety, mood, and obsessive-compulsive and related disorders","volume":"25","author":"Tolin","year":"2018","journal-title":"Assessment"},{"issue":"4","key":"10.1016\/j.jad.2025.120437_bb0175","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1037\/0022-3514.85.4.756","article-title":"Les passions de l\u2019ame: on obsessive and harmonious passion","volume":"85","author":"Vallerand","year":"2003","journal-title":"J. Pers. Soc. Psychol."},{"issue":"3","key":"10.1016\/j.jad.2025.120437_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2307\/1386666","article-title":"Testing the death transcendence scale","volume":"32","author":"Vandecreek","year":"1993","journal-title":"J. Sci. Study Relig."},{"issue":"1","key":"10.1016\/j.jad.2025.120437_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1037\/0021-843X.103.1.18","article-title":"Structures of personality and their relevance to psychopathology","volume":"103","author":"Watson","year":"1994","journal-title":"J. Abnorm. Psychol."},{"issue":"2","key":"10.1016\/j.jad.2025.120437_bb0190","first-page":"248","article-title":"LSD use in the United States: examining user demographics and their evolution from 2015\u20132019","volume":"8","author":"Weleff","year":"2024","journal-title":"J. Psychedelic Stud."},{"issue":"3","key":"10.1016\/j.jad.2025.120437_bb0195","first-page":"279","article-title":"A systematic review of psychedelic-assisted psychotherapy for mental health: an evaluation of the current wave of research and suggestions for the future","volume":"7","author":"Wheeler","year":"2020","journal-title":"Psychol. Conscious. Theory Res. Pract."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725018798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725018798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:56:15Z","timestamp":1780822575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725018798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"alternative-id":["S0165032725018798"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120437","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120437"}}